SFX by Ex Libris Inc.

Title:	Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking
Source:	Science [0036-8075] Alferink, J yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Aigner, S. "Peripheral T-cell tolerance: the contribution of permissive T-cell migration into parenchymal tissues of the neonate." Immunological reviews 169 (1999): 255-61.
description	2.	Rosenberg, Steven A. "Raising the Bar: The Curative Potential of Human Cancer Immunotherapy." Science translational medicine 4.127 (2012): 127-127.
description	3.	Mottet, M. "The role of the thymus in the integrated evolution of the recombinase-dependent adaptive immune response and the neuroendocrine system." Neuroimmunomodulation 18.5 (2011): 314-319.
description	4.	van Breda Vriesman, P J J. "The lesions of cyclosporine-induced autoimmune disease can be equally well elicited by CD4 or CD8 effector T cells." Transplantation 62.10 (1996): 1468-76.
description	5.	Restifo, Nicholas P. "Adoptive immunotherapy for cancer: harnessing the T cell response." Nature reviews. Immunology 12.4 (2012): 269-281.
description	6.	Arnold, B. "Cutting edge: IL-7-dependent homeostatic proliferation of CD8+ T cells in neonatal mice allows the generation of long-lived natural memory T cells." The journal of immunology 172.1 (2004): 15-9.
description	7.	Morgan, D J J. "Ontogeny of T cell tolerance to peripherally expressed antigens." Proceedings of the National Academy of Sciences of the United States of America 96.7 (1999): 3854-8.
description	8.	Adkins, B. "Heterogeneity in the CD4 T Cell Compartment and the Variability of Neonatal Immune Responsiveness." Current immunology reviews (2007): 151-159.
description	9.	Anderson, G. "Lymphostromal interactions in thymic development and function." Nature reviews. Immunology 1.1 (2001): 31-40.
description	10.	Lawson, David H. "gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma." The New England journal of medicine 364.22 (2011): 2119-2127.
description	11.	Anderson, Mark S. "Aire and T cell development." Current opinion in immunology 23.2 (2010): 198-206.
description	12.	Bendle, Gavin M. "Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy." Nature Medicine 16.5 (2010): 565-70.
description	13.	Jenq, R. "Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer." Nature Reviews. Cancer 10.3 (2010): 213-221.
description	14.	Rosenberg, Steven A. "Overcoming obstacles to the effective immunotherapy of human cancer." Proceedings of the National Academy of Sciences of the United States of America 105.35 (2008): 12643-4.
description	15.	Gottlieb, S.L. L. "Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis." Nature medicine 1.5 (1995): 442-447.
description	16.	Pardoll, Drew M. "The blockade of immune checkpoints in cancer immunotherapy." Nature Reviews. Cancer 12.4 (2012): 252-264.
description	17.	Ritter, M A A. "The human thymic microenvironment: new approaches to functional analysis." Seminars in immunology 11.1 (1999): 13-21.
description	18.	Starr, Timothy K K. "Positive and negative selection of T cells." Annual review of immunology 21.1 (2003): 139-76.
description	19.	Palucka, K. "Cancer immunotherapy via dendritic cells." Nature Reviews. Cancer 12.4 (2012): 265-277.
description	20.	Gill, S. "Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies." Immunological reviews 263.1 (2015): 68-89.